GSK plc
.jpg?lang=simple) Head office in Brentford, London with the former GlaxoSmithKline logo, taken in July 2007 | |
| Formerly | GlaxoSmithKline (2000–2022) |
|---|---|
| Company type | Public |
| Industry | |
| Predecessors |
|
| Founded | 27 December 2000 |
| Headquarters | London, England, UK |
Area served | Worldwide |
Key people |
|
| Products | |
| Revenue |  GB£31.376 billion (2024)[1] |
 GB£4.021 billion (2024)[1] | |
| GB£2.951 billion (2024)[1] | |
| Total assets | GB£59.463 billion (2024)[1] |
| Total equity | GB£13.086 billion (2024)[1] |
Number of employees | 70,000 (2025)[2] |
| Subsidiaries | |
| Website | www |
GSK plc, which used to be called GlaxoSmithKline plc. It is a multinational drug and biotechnology company with global headquarters in London, It is the is the tenth largest drug company.
It was started in 2000 when Glaxo Wellcome and SmithKline Beecham joined together. Its market capitalisation was £60 billion in May 2023. [3]
It made the first malaria vaccine in 2014.[4]
References
[change | change source]- ↑ 1.0 1.1 1.2 1.3 1.4 "Preliminary Results 2024" (PDF). GSK. Retrieved 9 February 2025.
- ↑ "At a glance". GSK. Retrieved 9 February 2025.
- ↑ "FTSE All-Share Index Ranking". www.stockchallenge.co.uk. Retrieved 2023-05-20.
- ↑ Plumridge, Hester (2014-07-24). "Glaxo Files Its Entry in Race for a Malaria Vaccine". Wall Street Journal. ISSN 0099-9660. Retrieved 2023-05-20.
.svg?lang=simple)
